Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed the sale of its microbiology business to Astorg, a leading pan-European private equity firm, forconsideration of approximately $1.075 billion, consisting of cash and a $50 million seller note. The microbiology business provides antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical and food safety testing. About Thermo Fisher ScientificThermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Gibco, Fisher Scientific, Unity Lab Services, Patheon and PPD. View source version on businesswire.com: https://www.businesswire.com/news/home/20260812171039/en/Contacts:Media Contact Information:Sandy PoundThermo Fisher ScientificPhone: 781-622-1223E-mail: sandy.pound@thermofisher.comInvestor Contact Information:Rafael TejadaThermo Fisher ScientificPhone: 781-622-1356E-mail: rafael.tejada@thermofisher.com